This inventor holds 5 USPTO granted patents and 5 published patent applications and 2 EPO patents. Top assignee: Quest Diagnostics Investments, Inc.. Active years: 2020-2025.
Location History:
- Temecula, CA (US) (2020 - 2021)
- San Clemente, CA (US) (2024)
Company Filing History:
Years Active: 2020-2025
Title: Thomas C Lynn: Innovator in Mass Spectrometry
Introduction
Thomas C Lynn is a notable inventor based in San Clemente, CA (US). He has made significant contributions to the field of mass spectrometry, holding a total of 5 patents. His work focuses on the detection and quantification of various biochemical compounds, which has important implications in medical diagnostics.
Latest Patents
Among his latest patents is the invention titled "Mass spectrometric determination of tert-butyldimethylsilyl derivatized methylmalonic acid." This invention relates to the detection of methylmalonic acid (MMA) and outlines methods for detecting derivatized MMA by mass spectrometry. Another significant patent is "Detection and quantitation of guanidinoacetate, creatine, and creatinine by mass spectrometry." This patent provides methods for detecting or determining the amounts of guanidinoacetate (GAA), creatine, and creatinine using mass spectrometry.
Career Highlights
Thomas C Lynn is currently associated with Quest Diagnostics Investments, Inc., where he continues to innovate in the field of mass spectrometry. His work has been instrumental in advancing diagnostic techniques that are crucial for patient care.
Collaborations
Throughout his career, Thomas has collaborated with notable colleagues such as Scott Goldman and Julie A Neidich. These collaborations have further enhanced the impact of his inventions in the scientific community.
Conclusion
Thomas C Lynn is a distinguished inventor whose work in mass spectrometry has led to significant advancements in biochemical detection methods. His contributions are vital for improving diagnostic capabilities in healthcare.